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Effects of administration of estradiol-17P on the 
serum and anterior pituitary IGF system in pigs 
L.A. Rempel and J.A. Clapper 
Department of Animal and Range Sciences 
SDSU SWINE 2001-17 
The anterior pituitary (AP) gland functions as 
a storage and releasing unit for several 
hormones; growth hormone (GH), gonadotropins 
(luteinizing hormone and follicle stimulating 
hormone), prolactin, adrenocorticotropin 
hormone, and thyroid stimulating hormone. 
Luteinizing hormone (LH) functions to increase 
ovarian follicular growth and maturation and 
responds to increasing concentrations of 
estradiol-17P (E2) that occur at estrus to cause 
ovulation. Production and secretion of the 
protein, insulin-like growth factor-I (IGF-1), 
occurs primarily in the liver, in response to GH 
release from the anterior pituitary gland. Insulin-
like growth factor-I increases glucose uptake, 
amino acid transport, and glycogen synthesis 
resulting in increased protein accretion. 
Mitogenic effects of IGF-1 can be manifested by 
increases in DNA, RNA, and protein. 
Furthermore, IGF-1 stimulates differentiation at 
low levels usually preceding a mitogenic 
response. The biological effects of IGF-1 are 
mediated by it's interaction with the IGF type I 
receptor and modulated by IGF binding proteins 
(IGFBPs). Insulin-like growth factor:1, IGFBPs, 
and IGF receptors have been detected in the AP 
gland of several species and may exert 
regulatory effects at the hypothalamic-
hypophyseal level affecting gonadotropins, and 
in turn, reproductive performance. 
There is evidence to suggest that estrogens 
can increase serum and AP concentrations of 
IGF-1 as well as expression of certain IGFBPs 
within the AP gland. Previous research has 
demonstrated that fluctuations in components of 
the IGF system can influence gonadotroph 
function. Addition of IGF-1 to dispersed AP cells 
obtained from gilts in either the follicular or luteal 
phase of the estrous cycle increased 
gonadotropin releasing hormone (GnRH) 
stimulated LH secretion over that in cells treated 
with no IGF-1. Studies have shown that 
administration of E2 to pituitary tumor cells 
increases production of IGF-1 and IGFBP-3. 
Changes in relative amounts of pituitary IGFBPs 
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have been noted throughout the bovine estrous 
cycle. Extended treatment of steers with 
exogenous estradiol resulted in increased serum 
concentrations of IGF-1. Simpson and co-
workers found that treating ovariectomized cows 
with estradiol for 45 days increased pituitary 
gland weight and resulted in greater plasma 
concentrations of IGF-1 and total plasma IGFBP 
activity compared to control cows. 
Steroid implants have long been used in 
cattle to improve growth and performance. By 
using such implants producers have improved 
feed efficiency and decreased feed costs, thus 
increasing their profitability. Use of E2 and 
trenbolone acetate (TBA) implants elicited an 
increase in circulating levels of IGF-1 stimulating 
muscle growth in crossbred yearling steers. 
Wethers treated with E2 and TBA also had 
increased serum concentrations of IGF-1 and 
had improved average daily gain and feed 
efficiency. Research has shown that boars 
produce and secrete greater amounts of E2 , of 
testicular origin, and produce leaner carcasses 
than gilts or barrows. A study conducted in our 
lab with prepubertal boars, found that rising 
serum concentrations of IGF-1 paralleled rising 
serum concentrations of E2. Similarly, feed 
efficiency was greater in boars than in gilts or 
barrows (castrated males.). 
The AP IGF system in swine has not been 
well defined. The effects of E2 on AP function 
may be partially explained by changes in 
components of the IGF system. A thorough 
understanding of the porcine AP IGF system, is 
a necessary first step .in developing strategies to 
control pituitary function that enhance 
reproduction and growth. Improved reproductive 
and growth performance will ultimately have a 
positive economic impact on the producer. 
We performed a preliminary study to 
determine if administration of E2 implants (25. 7 mg E2) could elevate serum concentrations 
of E2 in barrows similar to that of boars of 
comparable age and maturity and subsequently 
affect the AP IGF system. Twenty crossbred 
barrows were randomly assigned by litter to one of 
four treatment groups .of five barrows each. 
Treatment groups were as follows; 1) two implants, 
2) three implants, 3) four implants, and 4) no 
implants. 
This preliminary study determined that 
administration of E2 implants elevated serum 
concentrations of E2 in barrows over a 35-day 
period similar to what is found in gonadally intact 
boars of comparable age. Mean serum 
concentrations of E2 for barrows receiving 0, 2, 3, or 
4 implants were 11.7, 58.6, 78.3, and 87.4 pg/ml, 
respectively. Anterior pituitary concentrations of 
IGF-1 were increased (P<.05) by implantation with 
E2 versus no implant (623.2 ± 73.8 ng/ml versus 
208.2 ± 73.8 ng/ml, respectively.) Serum 
concentrations of IGF-1 were also increased (P<.05) 
in implanted barrows versus non-implanted from 
day 7 through day 35 of the experiment. Mean 
serum concentrations of IGF-1 in implanted barrows 
were 196.4 ± 10.3 ng/ml compared to 141.1 ± 
10.3 ng/ml in barrows without implants. Implant 
effects on serum IGF-1 levels were not dose 
dependent (P>.05). Feed efficiency, measured by 
G/F ratios, was greater (P<.05) in implanted 
animals versus those without implants. Feed 
efficiency of barrows with zero and two implants 
was not different (P> .05), whereas, barrows with 
three and four implants had an improved (P<.05) 
feed efficiency compared to controls, but were not 
different from barrows with two implants (P> .05). 
Our preliminary work indicated that E2 does 
regulate the IGF system in swine. Both serum and 
AP concentrations of IGF-1 were increased after 
administration of E2• These data suggest that boars 
and gilts, which naturally produce E2, have greater 
serum and AP concentrations of IGF-1 and may 
influence growth and reproductive performance. 
Further investigations are required to determine if 
boars and gilts have similar responses to 
endogenous E2 • 
A second experiment was designed to 
determine if administration of E2 to barrows 
increases components of the IGF system to levels 
similar to that found in boars of similar age and 
weight. Hypophyseal concentrations of IGF-1, 
serum concentrations of E2 and IGF-1, relative 
amounts of serum and AP IGFBPs, and 
concentrations of AP LH and GH were analyzed in 
barrows after administration of E2 and compared to 
boars and nonaimplanted barrows. 
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Three groups of pigs were randomly allotted by 
litter; boars (n=11 ), non-implanted barrows (n=12), 
and E2 implanted barrows (n=9). All pigs were 
penned individually throughout the experiment. 
Implanted barrows were administered two E2 
implants (25.7 mg E2 ,each) subcutaneously at the 
base of each ear on d 1. Blood samples, body 
weight, and feed disappearance was collected 
every two weeks thereafter and at slaughter (d 90). 
Chronic administration of E2 to barrows 
increased (P<.05) serum concentrations of E2 in 
implanted barrows versus boars. Serum 
concentrations of T increased (P<.05) over time in 
the boars from d O to d 90. Administration of E2 to 
implanted barrows increased (P<.05) AP 
concentrations of IGF-1 compared to boars and non-
implanted barrows, · but had no affect (P> .05) on 
relative ,amounts of serum and AP IGFBPs. Mean 
serum concentrations of IGF-1 tended to be- greater 
(P=.08) in implanted barrows versus non-implanted 
barrows. Gain to feed ratios increased in the 
implanted barrows versus control barrows, but 
boars grew more efficiently than implanted barrows. 
In collaboration with Dr. Andy Roberts at the Meat 
Animal Research Center in Clay Center, Nebraska, 
we were able to identify two IGFBPs in the AP 
gland, IGFBP-2 and · -5, through 
immunoprecipitation. Relative amounts of each of 
these AP IGFBPs were greater (P<.05) in boars 
than either barrows with or without E2 implants. To 
date, no one has published such a find in the 
porcine pituitary gland. 
Estradiol is believed to have a great impact on 
the IGF system in ruminant animals. Ourwork has 
led us to conclude that E2 plays a primary role in 
the porcine AP IGF system. The use of E2 in the 
barrow allowed us to use a model with levels of 
endogenous E2 at nearly zero. However, at the 
same time we eliminated other testicular hormones 
and factors. Our study implies that the boar 
produces and secretes other hormones and factors 
that could work synergistically or additively in the 
regulation of the AP IGF system. Analyses 
presently being conducted include the quantification 
of expression for IGF-1, IGF-1 receptor, and IGFBPs, 
to substantiate our hypothesis that E2 upregulates 
components of the porcine AP IGF system. 
Furthermore, our lab will also determine if AP 
concentrations o( IGF-1 are related to expression of 
GnRH receptor, a sub-unit, and LH 13 and FSH 13 
sub-units. 
